Back to Search
CRAIG STERNBERG, M.D.
M.D.
Sports Medicine (Physical Medicine & Rehabilitation) Physician
NPI: 1487688420Individual
Specialties, Licenses & Credentials
Sports Medicine (Physical Medicine & Rehabilitation) PhysicianPrimary
Physical Medicine & Rehabilitation — Sports Medicine
Code: 2081S0010X
C10002806(DE)
Research & Publications (20)
Docetaxel plus oblimersen sodium (Bcl-2 antisense oligonucleotide): an EORTC multicenter, randomized phase II study in patients with castration-resistant prostate cancer.
PMID 19297314·Ann Oncol·2009
3-trial
Expanding the boundaries of clinical practice: building on experience with targeted therapies.
PMID 19430002·Ann Oncol·2009
8-other
Antiangiogenic therapy in renal cell carcinoma: a plethora of choices.
PMID 18607403·Nat Clin Pract Urol·2008
8-other
Systemic chemotherapy and new experimental approaches in the treatment of metastatic prostate cancer.
PMID 18790987·Ann Oncol·2008
8-other
Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer.
PMID 17280909·Urology·2007
6-review
Molecular pathways and the hope of targeting angiogenesis.
PMID 17622236·Nat Clin Pract Urol·2007
8-other
Perioperative chemotherapy in muscle-invasive bladder cancer to enhance survival and/or as a strategy for bladder preservation.
PMID 17382795·Semin Oncol·2007
1-meta
The medical management of prostate cancer: a multidisciplinary team approach.
PMID 16956362·BJU Int·2007
6-review
What has been learned from meta-analyses of neoadjuvant and adjuvant chemotherapy in bladder cancer?
PMID 16925739·BJU Int·2006
8-other
Adjuvant bicalutamide for early prostate cancer: an update.
PMID 16902511·Nat Clin Pract Urol·2006
8-other
Apples and oranges. Re: 7.4-year update of the ongoing bicalutamide Early Prostate Cancer (EPC) trial programme.
PMID 16469001·BJU Int·2006
8-other
Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours.
PMID 16330205·Eur J Cancer·2006
3-trial
Phase III trial of satraplatin, an oral platinum plus prednisone vs. prednisone alone in patients with hormone-refractory prostate cancer.
PMID 15741753·Oncology·2005
3-trial
Development of and clinical experience with capecitabine (Xeloda) in the treatment of solid tumours.
PMID 15341878·Eur J Oncol Nurs·2004
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 87B OMEGA DR
NEWARK, DE 19713 - Phone
- (302) 733-0980
Quick Facts
- NPI
- 1487688420
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile